Global Neurodiagnostics Market: Overview
Neurodiagnostic devices are utilized in the diagnosis of neurological disorders. Various disorders like Parkinson’s disease, epilepsy, migraine, stroke are diagnosed with the help of neurodiagnostics. Neurodiagnostics contain a wide range of products including imaging and diagnostic systems and in-vitro diagnostics. The diagnostic and imaging system consists of various equipment like PET scanner, MRI scanner, and CT scanner. The neurodiagnostic products record and monitor the electrical activities of the spinal cord, brain, and peripheral nerves of the human body.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Neurodiagnostics Market: Growth Factors
Neuroimaging techniques help in studying and understanding the human brain and neural disorders. The ongoing technological advancements facilitate effective and non-invasive imaging results to offer a full view of the human brain along with its structure and functions in different regions. Each imaging technique is targeted at a particular area of the body. For example, MRI and CT techniques are used to find the developmental malformations of the human brain at the very initial stages. MRI is vital in examining genetic metabolic disorders in children. Brain scanning is very important in the diagnosis of mental disorders like bipolar disorder, depression, anxiety and autism. The growing awareness among patients regarding the effective treatment on early diagnosis of diseases is likely to escalate the growth of the global neurodiagnostics market manifolds in the forthcoming years. The constantly increasing geriatric population globally poses a huge demand for neurodiagnostics. Furthermore, the advancements in the field of proteomics and genomics along with the constantly growing number of diagnostic and hospital centers globally will also fuel the growth of the market. The government is taking several initiatives to lower the burden of rising neurological disorders on public hospitals owing to the fact that public health centers have limited facilities at disposal. Thereby, the governments of several regions are launching many favorable schemes and medical policies to assist private healthcare and diagnostic centers grow. The growing adoption of biological profiling for the diagnosis of several neurological diseases is likely to create several lucrative growth opportunities in the global neurodiagnostics market. Neurological biomarkers are widely adopted for diagnosing such disorders in research settings. Biomarkers facilitate a whole new dynamic to study neuro disorders and their associated epidemiology in clinical trials. The innovation of biomarkers aims to diagnose neurological diseases at an early age. Neuroinformatics is a branch that integrates neuroscience with information technology. Neuroinformatics helps in achieving advanced integration of all the stats to effectively understand these disorders by gathering data in the form of a huge database. It primarily operates on brain-computer interface data, cognitive data, cellular data, and molecular data.
Global Neurodiagnostics Market: Segmentation
The global neurodiagnostics market can be segmented into end-user, condition, product, and region.
By end-user, the market can be segmented into neurology centers, diagnostic laboratory & imaging centers, hospital & surgery centers, and others. The diagnostic laboratory & imaging center segment accounts for the largest share in the global neurodiagnostics market due to the financial ability of diagnostic laboratories to purchase advanced equipment like neurodiagnostic devices to study and examine various disorders.
By condition, the market can be segmented into sleep disorders, headache disorders, stroke, epilepsy, neurodegenerative diseases, and others.
By product, the market can be segmented into in-vitro diagnostics and diagnostic & imaging systems. The in-vitro diagnostics segment can further be bifurcated into molecular diagnostics and others.
The diagnostic & imaging system segment can further be bifurcated into computed tomography scanners, ultrasound imaging systems, magnetic resonance imaging systems, electroencephalogram systems, and others.
Global Neurodiagnostics Market: Regional analysis
North America accounts for the largest share in the global neurodiagnostics market due to the high prevalence of neurodegenerative diseases like epilepsy and Parkinson’s disease in the region. Furthermore, the ongoing technological advancements in the field of diagnostics are likely to further create several lucrative growth opportunities in the regional market. Also, the presence of prominent leaders offering advanced diagnostic devices will also fuel the growth of the regional market.
Asia Pacific is likely to be the fastest-growing region in the global neurodiagnostics market due to the growing number of diagnostic laboratories and research centers in the region. Growing disposable income of the people is encouraging them to adopt premium services and get advanced treatment for the neurological disorder is likely to further accentuate the growth of the regional market in the forthcoming years.
Global Neurodiagnostics Market: Competitive Players
Some of the significant players in the global neurodiagnostics market are Ridge Diagnostics, ELMIKO MEDICAL Sp. Z o.o., Neusoft Medical Systems Co., Ltd., Rigaku Corporation, Motion Lab Systems, Inc., Tecan Trading AG, DRG Instruments GmbH, Fujirebio, Fonar Corporation, ANT Neuro, Nihon Kohden Corporation, QIAGEN N.V., Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., Advanced Brain Monitoring, Mitsar Co., Ltd., FUJIFILM Holdings Corporation, Hoffman-La Roche AG, Natus Medical Incorporated, Lifelines Neuro Company, LLC, and Canon, Inc.
Global Neurodiagnostics Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets
Neuroimaging techniques help in studying and understanding the human brain and neural disorders. The growing awareness among patients regarding the effective treatment on early diagnosis of diseases is likely to escalate the growth of the global neurodiagnostics market manifolds in the forthcoming years.
Some of the significant players in the global neurodiagnostics market are Ridge Diagnostics, ELMIKO MEDICAL Sp. Z o.o., Neusoft Medical Systems Co., Ltd., Rigaku Corporation, Motion Lab Systems, Inc.
North America accounts for the largest share in the global neurodiagnostics market due to the high prevalence of neurodegenerative diseases like epilepsy and Parkinson’s disease in the region. Furthermore, the ongoing technological advancements in the field of diagnostics are likely to further create several lucrative growth opportunities in the regional market.